Nihon Kohden, a global leader in medical device innovation for high-precision patient monitoring and diagnostics, announces the acquisition of a 71.4% stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical Instrument Corporation (Ad-Tech), a trusted provider of specialized electrodes for epilepsy treatment and neurodiagnostic procedures. The move further solidifies Nihon Kohden’s position as an industry leader by combining its established expertise in EEG systems with Ad-Tech’s specialized intracranial electrodes—strengthening the company’s ability to address complex neurological conditions, including drug-resistant epilepsy.
Read the full article: Nihon Kohden Enhances Neurological Treatment through the Acquisition of Ad-Tech Medical Instrument Corporation //
Source: https://www.businesswire.com/news/home/20241112204199/en/Nihon-Kohden-Enhances-Neurological-Treatment-Through-the-Acquisition-of-Ad-Tech-Medical-Instrument-Corporation